NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

Active Not RecruitingN/A

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Conditions: Heart Failure

Interventions: Samtasu for I.V. infusion

Countries: Japan

To confirm the safety of tolvaptan sodium phosphate in patients with volume overload in heart failure.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\-

Exclusion Criteria:

* patients with a known hypersensitivity to Tolvaptan sodium phosphate or Tolvaptan

Locations (1)